Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non‐small‐cell lung cancer in New Zealand von McKeage, Mark J., Tin Tin, Sandar, Khwaounjoo, Prashannata, Sheath, Karen, Dixon‐McIver, Amanda, Ng, Daniel, Sullivan, Richard, Cameron, Laird, Shepherd, Philip, Laking, George R., Kingston, Nicola, Strauss, Magreet, Lewis, Christopher, Elwood, Mark, Love, Donald R.

Volltext

Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous ste... von Derman, Benjamin A., Stefka, Andrew T., Jiang, Ken, McIver, Amanda, Kubicki, Tadeusz, Jasielec, Jagoda K., Jakubowiak, Andrzej J.

Volltext

Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia von Dixon-McIver, Amanda, East, Phil, Mein, Charles A, Cazier, Jean-Baptiste, Molloy, Gael, Chaplin, Tracy, Andrew Lister, T, Young, Bryan D, Debernardi, Silvana

Volltext

Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2 von Snaddon, Jennifer, Smith, Matthew L., Neat, Michael, Cambal-Parrales, Maxine, Dixon-McIver, Amanda, Arch, Rachael, Amess, John A., Rohatiner, Ama Z., Lister, T. Andrew, Fitzgibbon, Jude

Volltext

53. Uveal melanoma - The New Zealand perspective von Dixon-McIver, Amanda, Han, Catherine, Kumar, Gini

Volltext

Incorporation of COVID-19 variant testing within a community laboratory using the TaqMan SARS-CoV-2 Mutation Panel von Ha, Emily, Dixon-McIver, Amanda

Volltext

59. What the TERT? - A telomerase reverse transcriptase case study von Moodley, Yeshmira, Yang, Longqian, Neumann, Bronwyn, Dixon-McIver, Amanda

Volltext

Determining the optimal input DNA concentration range for AmpFLSTR® identifier™ assay von Ward-Hayes, Harry, Dixon-McIver, Amanda

Volltext

NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRAS Q61R or KRAS Q61R Mutation in Colorectal Carcinoma von Turchini, John, Andrici, Juliana, Sioson, Loretta, Clarkson, Adele, Watson, Nicole, Toon, Christopher W., Shepherd, Phillip, Ng, Daniel, Dixon-McIver, Amanda, Oei, Paul, Gill, Anthony J.

Volltext

10. Uveal melanoma: The New Zealand perspective von Dixon-McIver, Amanda, Kumar, Gini, Han, Catherine

Volltext

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma von Jakubowiak, Andrzej J., Jasielec, Jagoda K., Rosenbaum, Cara A., Cole, Craig E., Chari, Ajai, Mikhael, Joseph, Nam, Jennifer, McIver, Amanda, Severson, Erica, Stephens, Leonor A., Tinari, Kathryn, Rosebeck, Shaun, Zimmerman, Todd M., Hycner, Tyler, Turowski, Agata, Karrison, Theodore, Zonder, Jeffrey A.

Volltext

Prospective Trial Using Multimodal Measurable Residual Disease Negativity to Guide Discontinuation of Maintenance Therapy in Multiple Myeloma (MRD2STOP) von Derman, Ben A., Major, Ajay, Major, Sarah, Wolfe, Brittany D., Gorski, Martha, Cooperrider, Jennifer H., Andreatos, Evangelia, Jiang, Ken, Buckley, Karson, McIver, Amanda, Stefka, Andrew, Jakubowiak, Andrzej

Volltext

Measurable residual disease (MRD) assessed by mass spectrometry (MS) in peripheral blood versus next generation sequencing (NGS) in bone marrow in multiple myeloma treated on phase... von Derman, Benjamin Avi, Stefka, Andrew T, McIver, Amanda, Jiang, Ken, Kubicki, Tadeusz, Jasielec, Jagoda, Jakubowiak, Andrzej J.

Volltext

A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma von Derman, Ben A, Major, Ajay, Rosenblatt, Jacalyn, Avigan, David, Rampurwala, Murtuza M., Alcantar, Luis, Libao, Bernadette M., McIver, Amanda, Andreatos, Evangelia, Major, Sarah, Wolfe, Brittany, Gorski, Martha, Karrison, Theodore G., Stefka, Andrew, Jakubowiak, Andrzej

Volltext

Impact of an oncology clinical pharmacist specialist in an outpatient multiple myeloma clinic von Virani, Amin, Schlei, Zach, Jakubowiak, Andrzej J., Jasielec, Jagoda, Gleason, Christine, Ackermann, Megan, Wolfe, Brittany, Major, Sarah, McIver, Amanda, Parsad, Sandeep

Volltext

Emerging technologies in paediatric leukaemia von Dixon-McIver, Amanda

Volltext

Impact of an Oncology Clinical Pharmacist Specialist in an Outpatient Multiple Myeloma Clinic von Virani, Amin, Schlei, Zachary, Gleason, Christine, Ackermann, Megan, Wolfe, Brittany, Major, Sarah, McIver, Amanda, Jakubowiak, Andrzej J., Jasielec, Jagoda, Parsad, Sandeep

Volltext

Interim analysis of a phase 2 minimal residual disease (MRD)-adaptive trial of elotuzumab, carfilzomib, lenalidomide, and dexamethasone (Elo-KRd) for newly diagnosed multiple myelo... von Derman, Benjamin Avi, Zonder, Jeffrey A., Kansagra, Ankit J., Grinblatt, David L., Narula, Sunil, Rayani, Shayan, Stefka, Andrew T, Jiang, Ken, Major, Sarah, Wolfe, Brittany, Whelan, Megan, Libao, Bernadette, McIver, Amanda, Andreatos, Evangelia, Juergens, Daniel, Alcantar, Luis, Karrison, Theodore, Bishop, Michael Russell, Jasielec, Jagoda, Jakubowiak, Andrzej J.

Volltext

Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study von Jasielec, Jagoda, Zonder, Jeff, Derman, Benjamin A, Reece, Donna E., Cole, Craig E., Berdeja, Jesus G., Wolfe, Brittany, Major, Sarah, Tinari, Kathryn M., Stefka, Andrew, Fazzi, Fabrizio, Whelan, Megan, Gleason, Christine, McIver, Amanda, Andreatos, Evangelia, Libao, Bernadette M., Juergens, Daniel, Griffith, Kent, Jakubowiak, Andrzej

Volltext

Validation of a molecular assay to detect SARS-CoV-2 in saliva von Pitman, Janet L

Volltext